
Cong Chen
Articles
-
Jan 19, 2025 |
tandfonline.com | Thomas Jemielita |Cong Chen
ABSTRACTRandomized clinical trials (RCTs) can benefit from using Real-World Data (RWD) as a supplementary data source to enhance their analysis. An Augmented RCT combines randomized treatment and control groups with synthetic controls derived from RWD. This way, the trial can achieve less prospective enrollment, higher statistical power, and lower costs. However, to ensure scientific validity, the synthetic controls must satisfy the same eligibility criteria as the trial participants.
-
Dec 6, 2024 |
pubs.rsc.org | Haiyang Wang |Cong Chen |Junxia Shen |Pierre-Yves Olu
Self-supported Ni/NiO heterostructures with a controlled reduction protocol for enhanced industrial alkaline hydrogen evolution† Self-supported Ni/NiO heterostructures with controllable ratios used in industrial alkaline water electrolysis (AWE) systems lead to an ultralow voltage of 1.79 V at 400 mA cm−2 for 2 weeks, ascribed to the synergic combination of abundant active sites, rapid electron/mass transfer and optimal HER kinetics.
-
Nov 25, 2024 |
pubs.rsc.org | Haiyang Wang |Cong Chen |Junxia Shen |Pierre-Yves Olu
Self-supported Ni/NiO heterostructures with controlled reduction protocol for enhanced industrial alkaline hydrogen evolution Self-supported Ni/NiO heterostructures with controllable ratios used in industrial alkaline water electrolysis (AWE) system leads to an ultralow voltage of 1.79 V at 400 mA cm-2 for 2 weeks, ascribed to the synergic combination of abundant active sites, rapid electron/mass transfer and optimal HER kinetics.
-
Nov 13, 2024 |
mdpi.com | Tianfeng Zhou |Cong Chen |Cong Dong |Qinghua Li
All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.
-
Oct 19, 2024 |
biorxiv.org | Cong Chen |Hua-Wei Yi |Yi Zhang |Tong-Yao Gao
AbstractUbiquitin (Ub), a key player of protein turnover, can be phosphorylated by PINK1 kinase to generate S65-phosphorylated ubiquitin (pUb). Elevated pUb levels have been observed in aged and Parkinson's diseases afflicted human brains. However, how pUb is involved in neurodegeneration remains elusive. Here we show that elevation of pUb is pervasive in various neurodegenerative conditions, including Alzheimer's disease, aging, and ischemic injury.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →